Empowered Patient Podcast

Tim Moran, President and CEO of Avertix, discusses the company's mission to revolutionize how heart attack survivors are cared for and supported. Targeting patients who have had one prior heart attack or instance of a prior acute coronary syndrome, this first-of-its-kind technology is implanted in patients to monitor for the onset of another heart attack. The device notifies the patient in real-time so they can seek care and minimize the effects of the attack.  Work is underway for providing cloud connectivity to the device, allowing data to be shared with physicians and family members.   Tim explains, "So in our study, patients that had The Guardian product implanted, we were able to reduce their time to care from the onset of symptoms by almost eight times. So we got the time down on average to 1.6 hours from the onset of symptoms where they arrived at an emergency room and then ultimately could have therapeutic intervention like a stent put in, which ultimately would reperfuse them and get blood flowing a